Latest filing published 02 Mar 2017 for AbbVie Inc., €12k.
Filing timeline
BuySaleInsider track record
Thomas A. Hurwich: trading record in brief
All filings by Thomas A. Hurwich on record concern AbbVie Inc. Between 14 February 2013 and 28 February 2017, the trades on record add up to 39 filings.
Every open-market trade on record is a sale: 11 sales worth €1.2M. Other entries cover 16 share grants and 11 option exercises. So far in 2017, the count stands at no purchases and 3 sales.
On 2 March 2017 came the latest disclosure, a share grant for €291k in AbbVie Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Thomas A. Hurwich
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 200 shares@ US$61.890.8% of flowCommon stock, $0.01 par valueSEC:0001179110-17-003703:0
- 1,911 shares@ US$61.897.5% of flowCommon stock, $0.01 par valueSEC:0001179110-17-003703:1
- 200 shares@ US$61.900.8% of flowCommon stock, $0.01 par valueSEC:0001179110-17-003703:2
- 4,947 shares@ US$62.2219.5% of flowCommon stock, $0.01 par valueSEC:0001179110-17-003703:3
- 5,612 shares0Common stock, $0.01 par valueSEC:0001179110-17-002810:0
- 2,526 shares0Common stock, $0.01 par valueSEC:0001179110-17-002810:1
- 3,100 shares@ US$28.865.6% of flowCommon stock, $0.01 par valueSEC:0001179110-16-031870:0
- 3,100 shares@ US$62.0012.0% of flowCommon stock, $0.01 par valueSEC:0001179110-16-031870:1
- 755 shares0Common stock, $0.01 par valueSEC:0001179110-16-028396:0
- 6,000 shares@ US$27.299.7% of flowCommon stock, $0.01 par valueSEC:0001179110-16-024456:0
- 5,900 shares@ US$63.5922.2% of flowCommon stock, $0.01 par valueSEC:0001179110-16-024456:1
- 100 shares@ US$63.600.4% of flowCommon stock, $0.01 par valueSEC:0001179110-16-024456:2
- 4,812 shares@ US$56.0016.6% of flowCommon stock, $0.01 par valueSEC:0001179110-16-020679:0
- 1,444 shares@ US$55.254.9% of flowCommon stock, $0.01 par valueSEC:0001179110-16-020679:1
- 6,200 shares@ US$22.94Common stock, $0.01 par valueSEC:0001179110-15-008385:0
- 6,200 shares@ US$66.00Common stock, $0.01 par valueSEC:0001179110-15-008385:1
- 2,524 shares@ US$60.52Common stock, $0.01 par valueSEC:0001179110-15-004095:0
- 1,185 shares@ US$60.57Common stock, $0.01 par valueSEC:0001179110-15-004095:1
- 1,862 shares@ US$60.50Common stock, $0.01 par valueSEC:0001179110-15-004095:2
- 10,820 shares0Common stock, $0.01 par valueSEC:0001179110-15-003163:0
- 1,400 shares@ US$67.81Common stock, $0.01 par valueSEC:0001179110-14-017220:0
- 100 shares@ US$67.82Common stock, $0.01 par valueSEC:0001179110-14-017220:1
- 10,000 shares@ US$24.07Common stock, $0.01 par valueSEC:0001179110-14-016292:0
- 6,737 shares@ US$62.54Common stock, $0.01 par valueSEC:0001179110-14-016292:1
- 3,360 shares@ US$50.91Common stock, $0.01 par valueSEC:0001179110-14-004335:0
25 of 39 declarations
